Jun 30, 2020

Xenon Pharmaceuticals Q2 2020 Earnings Report

Total Revenue
$13.4M
EPS
-$0.005
Previous year: -$0.37
-98.6%
Gross Profit
$2.66M
Cash and Equivalents
$44.2M
Previous year: $37.1M
+19.2%
Free Cash Flow
-$11.2M
Previous year: -$8.87M
+25.8%
Total Assets
$211M
Previous year: $106M
+99.0%

Xenon Pharmaceuticals

Xenon Pharmaceuticals